Skip to main content
Article thumbnail
Location of Repository

Expression capable library for studies of Neisseria gonorrhoeae, version 1.0\ud

By Thomas S. (Thomas Scott) Brettin, Michael R. Altherr, Ying Du, Roxie M. Mason, Alexandra Friedrich, Laura Potter, Chris Langford, Thomas J. Keller, Jason Jens, Heather Howie, Nathan J. Weyand, Susan Clary, Kimberley Prichard, Susi Wachocki, Erica Sodergren, Joseph P. Dillard, George Dillard, Magdalene So and Cindy Grove Arvidson

Abstract

Background\ud The sexually transmitted disease, gonorrhea, is a serious health problem in developed as well as in developing countries, for which treatment continues to be a challenge. The recent completion of the genome sequence of the causative agent, Neisseria gonorrhoeae, opens up an entirely new set of approaches for studying this organism and the diseases it causes. Here, we describe the initial phases of the construction of an expression-capable clone set representing the protein-coding ORFs of the gonococcal genome using a recombination-based cloning system.\ud \ud Results\ud The clone set thus far includes 1672 of the 2250 predicted ORFs of the N. gonorrhoeae genome, of which 1393 (83%) are sequence-validated. Included in this set are 48 of the 61 ORFs of the gonococcal genetic island of strain MS11, not present in the sequenced genome of strain FA1090. L-arabinose-inducible glutathione-S-transferase (GST)-fusions were constructed from random clones and each was shown to express a fusion protein of the predicted size following induction, demonstrating the use of the recombination cloning system. PCR amplicons of each ORF used in the cloning reactions were spotted onto glass slides to produce DNA microarrays representing 2035 genes of the gonococcal genome. Pilot experiments indicate that these arrays are suitable for the analysis of global gene expression in gonococci.\ud \ud Conclusion\ud This archived set of Gateway® entry clones will facilitate high-throughput genomic and proteomic studies of gonococcal genes using a variety of expression and analysis systems. In addition, the DNA arrays produced will allow us to generate gene expression profiles of gonococci grown in a wide variety of conditions. Together, the resources produced in this work will facilitate experiments to dissect the molecular mechanisms of gonococcal pathogenesis on a global scale, and ultimately lead to the determination of the functions of unknown genes in the genome.\ud \u

Topics: R1, QR
Publisher: BioMed Central Ltd.
Year: 2005
OAI identifier: oai:wrap.warwick.ac.uk:581

Suggested articles

Citations

  1. (1991). Antimicrobial resistance: new directions.
  2. (2003). Arvidson CG: Identification of ZipA, an SRP-targeted protein from Neisseria gonorrhoeae. doi
  3. (2002). CA: The gonococcal fur regulon: identification of additional genes involved in major catabolic, recombination, and secretory pathways. doi
  4. (2000). CA: Unravelling the mysteries of virulence gene regulation in Salmonella typhimurium. Mol Microbiol doi
  5. (1998). Cell signaling by the type IV pili of pathogenic Neisseria. doi
  6. (2003). CG: A role for both DNA and RNA in GTP hydrolysis by the Neisseria gonorrhoeae signal recognition particle receptor. doi
  7. (2005). CG: Global gene expression and the role of sigma factors in Neisseria gonorrhoeae in interactions with epithelial cells. Infect Immun doi
  8. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature doi
  9. Disease Control and Prevention [ h t t p : / doi
  10. (2000). Do pathogenic neisseriae need several ways to modify the host cell cytoskeleton? Microbes Infect doi
  11. (1999). Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immun
  12. (1991). Expert system for predicting localization sites in Gram-negative bacteria. Proteins doi
  13. (1988). Falkow S: Model for invasion of human tissue culture cells by Neisseria gonnorrhoeae. Infect Immun
  14. (2003). FarR regulates the farAB-encoded efflux pump of Neisseria gonorrhoeae via an MtrR regulatory mechanism. doi
  15. (2000). GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Meth Enzymol doi
  16. (2002). Gonococcal genome sequencing project. URL http:// www.genome.ou.edu/gono/html.
  17. (1998). Gonococcal invasion of epithelial cells driven by P.IA, a bacterial ion channel with GTP binding properties. doi
  18. (2004). Gonococcal porin IB activates NF-kappaB in human urethral epithelium and increases the expression of host antiapoptotic factors. Infect Immun doi
  19. (1997). Gotschlich EC: Several carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity proteins. J Exp Med doi
  20. (1996). Griffiss JM: Does an experimental gonococcal infection protect human volunteers from subsequent reinfection? Abst Tenth Intnl Path Neisseria Conf
  21. (2001). HS: A variable genetic island specific for Neisseria gonorrhoeae is involved in providing DNA for natural transformation and is found more often in disseminated infection isolates. Mol Microbiol doi
  22. (1988). Identification and arrangement of the DNA sequence recognized in specific transformation of Neisseria gonorrhoeae. P r o c N a t l A c a d S c i U S A doi
  23. (2000). Interactions of pathogenic Neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol
  24. (1998). JF: In vivo and ex vivo regulation of bacterial virulence gene expression. Curr Opin Microbiol doi
  25. (1991). JG: Physical map of the chromosome of Neisseria gonorrhoeae FA1090 with locations of genetic markers, including opa and pil genes.
  26. (2005). JP: Neisseria gonorrhoeae secretes chromosomal DNA via a novel type IV secretion system. Mol Microbiol doi
  27. (2004). KP: The tmRNA website: reductive evolution of tmRNA in plastids and other symbionts. Nucleic Acids Res doi
  28. (1997). Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res doi
  29. (1988). Lipooligosaccharides: The principal glycolipids of the Neisserial outer membrane. Rev Infect Dis doi
  30. (2002). M: CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. doi
  31. Neisseria gonorrhoeae annotated genome sequence database.
  32. (1993). Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS doi
  33. (2003). Palzkill T: Systematic cloning of Treponema pallidum open reading frames for protein expression and antigen discovery. Genome Res doi
  34. (2005). PilT is required for PI(3,4,5)P3-mediated cross-talk between N. gonorrhoeae and epithelial cells. Cell Microbiol doi
  35. (1988). Purification, characterization, and comparison of the immunoglobulin A1 proteases of Neisseria gonorrhoeae.
  36. (1988). Rest RF: Gonococci possessing only certain P.II outer membrane proteins interact with human neutrophils. Infect Immun
  37. (1984). Rosenthal RS: Ability of monomeric peptidoglycon fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. doi
  38. (2003). RS: Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis. doi
  39. (1973). Sawyer WD: Role of pili in the virulence of Neisseria gonorrhoeae. Infect Immun
  40. sequence analysis package [http://sta den.sourceforge.net]
  41. (1995). Shafer WM: Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae.
  42. (1990). Shuttle mutagenesis of Neisseria gonorrhoeae: pilin null mutations lower DNA transformation competence.
  43. Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. doi
  44. (1985). Sparling F: Response of Neisseria gonorrhoeae to iron limitation: alterations in expression of membrane proteins without apparent siderophore production. Infect Immun
  45. (1983). Sparling PF: Epidemiologic notes and reports penicillin-resistant gonorrhea -- North Carolina. MMWR
  46. (1999). Stojiljkovic I: Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol doi
  47. (1973). Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells. doi
  48. (1997). Taylor RK: Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli. Mol Microbiol doi
  49. (1976). Taylor-Robinson D: Human fallopian tubes in organ culture: preparation, maintenance, and quantitation of damage by pathogenic microorganisms. Infect Immun
  50. (1981). Taylor-Robinson D: Pathogenic mechanisms of Neisseria gonorrhoeae: observations on damage to human Fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J Infect Dis doi
  51. (2003). TF: 'Small' talk: Opa proteins as mediators of Neisseria-host-cell communication. Curr Opin Microbiol doi
  52. (1997). TF: CD66 carcinoembryonic antigens mediate interactions between Opa- expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. doi
  53. (1995). TF: Neisseria PilC protein identified as type-4 pilus tip-located adhesin. Nature doi
  54. (2005). The N. gonorrhoeae type IV pilus stimulates mechanosensitive pathways and cytoprotection through a pilT-dependent mechanism. PLoS Biol doi
  55. (2001). The pilusinduced Ca2+ flux triggers lysosome exocytosis and increases the amount of Lamp1 accessible to Neisseria IgA1 protease. Cell Microbiol doi
  56. (1998). The Shigella flexneri virulence gene regulatory cascade: A paradigm of bacterial control mechanisms. Mol Microbiol doi
  57. (1999). TL: Blast 2 sequences - a new tool for comparing protein and nucleotide sequences. doi
  58. (1999). Type IV pili of pathogenic neisseriae elicit cortical plaque formation in epithelial cells. Mol Microbiol doi
  59. (1991). VL: Enhancement of the invasive ability of Neisseria gonorrhoeae by contact with Hec1B, an adenocarcinoma endometrial cell line. Mol Microbiol doi
  60. (1997). WL: Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis doi
  61. (1996). Wolf-Watz H: Modulation of virulence factor expression by pathogen target cell contact. Science doi
  62. World Health Organization [http://www.who.org]
  63. (1981). ZA: Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. doi
  64. (2002). Zenilman JM: Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.